Bioradiotherapy with Cetuximab May Reduce the Risk of Neck Node Relapse in Locoregionally Advanced Laryngeal Glottic Carcinoma: May HER1-Profile Be Useful in the Bioselection of Patients?

The aim of the study was to evaluate survival in patients with advanced glottic laryngeal squamous cell carcinoma treated by bioradiotherapy (BioRT) with cetuximab and eventual salvage surgery (group A, n = 66) or upfront surgery (total laryngectomy or near-total laryngectomy) with or without postop...

Descripción completa

Detalles Bibliográficos
Autores principales: Almadori, Giovanni, Coli, Antonella, De Corso, Eugenio, Settimi, Stefano, Mele, Dario Antonio, Brigato, Francesca, Scannone, Domenico, Galli, Jacopo, Valentini, Vincenzo, Paludetti, Gaetano, Lauriola, Libero, Ranelletti, Franco Oreste
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504760/
https://www.ncbi.nlm.nih.gov/pubmed/36143274
http://dx.doi.org/10.3390/jpm12091489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504760/
https://www.ncbi.nlm.nih.gov/pubmed/36143274
http://dx.doi.org/10.3390/jpm12091489

Ejemplares similares